Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P41181 (
collecting duct
)
5,183
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Affymetrix GeneChip technology was employed to detect differentially expressed genes in inner medullary
collecting duct
(IMCD3) cells grown under isotonic and hypertonic conditions. A marked up-regulation was found for the zinc-finger protein
ZAC1
under hypertonic stress (219-fold, p < 0.001). Changes in expression for
ZAC1
were verified by quantitative PCR for message and Western blotting for protein. In mouse and human kidney tissues,
ZAC1
expression was substantial in the papilla and was absent in the cortex. Furthermore,
ZAC1
expression significantly increased in the papilla of mice following 36 h of fluid restriction and decreased in polyuric mice consuming sucrose in water. Because
ZAC1
has been described to be a potential negative regulator of sorbitol dehydrogenase (SDH) in hippocampal cells, we examined whether this relationship also occurs in kidney cells under hypertonic stress. We found that stable IMCD3 clones silenced for
ZAC1
to varying levels demonstrated an inverse effect on SDH expression.
ZAC1
binds to a consensus repression site within the promoter of SDH, pointing to a mechanism whereby
ZAC1
acts by repressing SDH transcriptional activity during hypertonic conditions. Taken together, these data strongly suggest that
ZAC1
is up-regulated under hypertonic stress and negatively regulates expression of SDH, allowing for accumulation of sorbitol as a compatible organic osmolyte.
...
PMID:ZAC1 is up-regulated by hypertonicity and decreases sorbitol dehydrogenase expression, allowing accumulation of sorbitol in kidney cells. 1942 11